Indian drugmakers asks US Trade Representative body to restore faith in new trade policyIndian Pharma Alliance, a grouping of top domestic drugmakers, in its latest submission has urged the USTR to consider submissions of many ...
Pfizer's slams India's patent regime, says Indian standards are vague and malleableUS drugmaker Pfizer has slammed the patent regime in India, telling that all patents that the company has managed to get in India do not ha...
- Government plans to meet key demand of RIL, BG and Cairn India; may restrict CAG’s scrutiny
The government plans to restrict CAG's scrutiny of private oil and gas fields to financial matters instead of a full-fledged performance au...
Generic business may hit drug exports of Indian firms like Cipla and NatcoIndia exported medicines worth $13.2 billion last fiscal and the government plans to double it to $25 billion by March 2014.
- RIL refutes CAG charges, says BP Deal & reports validate stand
RIL has challenged the allegations of the CAG saying its response to the auditor's charges is endorsed by top global consultants and oil ma...
- RIL shows experts audits to counter CAG charges on KG-D6 field
RIL today brought out expert audits to justify its work and cost in discovering world's biggest gas find that was brought to production in ...